market america world conference 2009 elizabeth rogers b.s nutrametrix product manager
TRANSCRIPT
Isotonix® Vitamin D with K2
Market AmericaWorld Conference 2009
Elizabeth Rogers B.SnutraMetrix Product Manager
Isotonix® Vitamin D with K2
These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Vitamin D in the News
Vitamin D Deficiency
More than1 billion people worldwide do not consume adequate amounts of vitamin D
More than 50% of postmenopausal women taking medication for osteoporosis have suboptimal levels of vitamin D
Without adequate vitamin D, only 10-15% of dietary calcium is absorbed
Vitamin D
Fat-soluble vitamin Obtained in 3 ways:
› Dietary intake› Supplementation› Sunlight
Metabolically active form
Role of vitamin D
Promotes the proper synthesis and functioning of important proteins essential for proper calcium utilization
Supports the maintenance of bones Supports immune health Helps maintain cardiovascular health Helps maintain normal blood pressure
Dietary Sources of vitamin D
Salmon: 360 IUs Mackerel: 345 IUs Tuna: 200 IUs Sardines: 250 IUs Fortified Milk: 98 IUs
Why Vitamin K2?
Promotes normal calcium absorption Promotes healthy arteries Active form of vitamin K with highest
bioavailability Women with low bone density have
been found to be deficient in vitamin K Addresses the “calcium paradox”
Vitamin K1 vs. K2 Both are naturally occurring forms of
vitamin K Different chemical structures resulting in
different pharmacokinetic properties K1 is absorbed primarily in the liver
where at high doses it may interfere with anticoagulant medications
K2 is transported primarily to the bones and blood vessels
Only 10% of dietary vitamin K is in K2 form
Why take vitamins D and K as supplements?
Most people are vitamin D deficient or insufficient› Diet› Sun exposure
Very little vitamin K is stored in the body
These vitamins work together
Ingredients
Vitamin D3: 5,000 IU Vitamin K2: 45 mcg
Codes: 13071 (MA) 13972 (nutraMetrix) DC: $21.50 SR: $29.95 BV: 17
Benefits
Helps maintain bone health
Promotes normal bone mineral density
Promotes proper synthesis of proteins essential for proper calcium utilization
Helps maintain cardiovascular health
Promotes healthy arteries
Promotes elasticity of blood vessels
Helps maintain normal blood pressure
Promotes healthy cells
Supports immune health
Who would benefit?
Bone health Immune health Cardiovascular health Optimal nutrient absorption Optimizing overall health
How to Sell this Product Isotonic Vitamin D deficiency Calcium paradox
Code: 13071 (MA) 13972 (nutraMetrix) DC: $21.50 SR: $29.95 BV: 17
Bring your body to its best!
Distributor Cost: $21.50
Suggested Retail: $29.95
BV: 17
Product Code: 13071 (MA) 13972
(nutraMetrix)
BUY YOURS TODAY!!
References Gundberg C et al. Vitamin K status and bone health: an analysis of methods for
determination under carboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism. 83(9):3258-3266, 1998.
Weber P. Management of osteoporosis: is there a role for vitamin K? International Journal for Vitamin and Nutrition Research. 67(5):350-6, 1997.
Garber, A. K., et al. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. Journal of Nutrition. 129(6):1201-1203, 1999.
Binkley N et al. Vitamin K nutrition and osteoporosis. Journal of Nutrition. 125(7):1812-1821, 1995.
Bischoff-Ferrari Het al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 293(18):2257-2264, 2005.
Guirguis-Blake J et al. Oral vitamin D3 decreases fracture risk in the elderly. Journal of Family Practice. 52(6):431-435, 2003.
Schaafsma, A., et al. Vitamin D3 and vitamin K1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. European Journal of Clinical Nutrition. 54:626-631, 2000.
Trivedi Det al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal. 326(7387):469, 2003.
Van den Berghe G et al. Bone turnover in prolonged critical illness: effect of vitamin D. Journal of Clinical Endocrinology and Metabolism. 88(10):4623-4632, 2003.
Chapuy M et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 327(23):1637-1642, 1992.
Grant W and Holick M. Benefits and requirements of vitamin D for optimal health. Alternative Medicine Review. 10:94-111, 2005.
References Knapen M et al. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.
Osteoporosis International. 18(7):963-72, 2007. Shiraki, M., et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in
osteoporosis. Journal of Bone & Mineral Research. 15:515-522, 2000. Hiruma Y et al. Vitamin K(2) and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner.
Biochemical Biophysical Research Communications. 314(1):24-30, 2004. Plaza S and Lamson D. Vitamin K2 in bone metabolism and osteoporosis. Alternative Medicine Reviews. 10(1):24-35, 2005.
Review. Kameda T et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochemical and Biophysical
Research Communications. 220(3):515-519, 1996. Taira H et al. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors. Calcified Tissue International.
73(1):78-85, 2003. Hidaka T et al. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in
bone mineral density: effects of concomitant administration of vitamin K(2). Journal of Bone and Mineral Metabolism. 20(4):235-239, 2002.
Iwamoto J et al. Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design. 10(21):2557-2576, 2004. Iwamoto J et al. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. The Keio Journal of Medicine.
2003 Sep;52(3):147-50. Review. Neogi, T., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis and Rheumatism.
54(4):1255-1261, 2006. Price P. Role of vitamin K-dependent proteins in bone metabolism. Annual Review of Nutrition. 8:565-583, 1988. Bekner K. The vitamin K-dependent carboxylase. Journal of Nutrition. 130(8):1877-1880, 2000. Nelsestuen G et al. Vitamin K-dependent proteins. Vitamins and Hormones. 58:355-389, 2000. Shearer M. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Current Opinion
in Clinical Nutrition and Metabolic Care. 3(6):433-438, 2000. Habu D et al. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA.
292(3):358-361, 2004. Yoshida T et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung
cancer. International Journal of Oncology. 23(3):627-632, 2003. Lamson D and Plaza S. The anticancer effects of vitamin K. Alternative Medicine Review. 8(3):303-18, 2003. Yokoyama T et al. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer
cell lines. International Journal of Oncology. 26(1):33-40, 2005. Chlebowski R et al. Vitamin K in the treatment of cancer. Cancer Treatment Review. 12:49-63, 1985. Lamson D et al. The anticancer effects of vitamin K. Alternative Medicine Review. 8(3):303-318, 2003.
References
Hitomi M et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology. 26(3):713-720, 2005.
Nouso K et al. Regression of hepatocellular carcinoma during vitamin K administration. World Journal of Gastroenterology. 11(42):6722-6724, 2005.
Blackmore K et al. Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. American Journal of Epidemiology. 168(8):915-24, 2008.
Deluca H et al. Vitamin D: its role and uses in immunology. FASEB Journal. 15(14):2579-2585, 2001. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. International
Immunopharmacology. 2(7):1017-1028, 2002. Cantorna M et al. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease
prevalence. Experimental Biology and Medicine (Maywood). 229(11):1136-1142, 2004. Cantorna M. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune
disease prevalence? Society for Experimental Biology and Medicine. 223:230-233, 2000. Garland C et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 96(2):252-61,
2006. Giovannucci E et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in
men. Journal of the National Cancer Institute. 98(7):451-459, 2006. Holick, M. Vitamin D: Its role in cancer prevention and treatment. Progress in Biophysics and Molecular
Biology. 92(1):49-59, 2006. Gorham E et al. Vitamin D and prevention of colorectal cancer. Journal Steroid Biochemistry and Molecular
Biology. 97(1-2):179-94, 2005. Grant W et al. Reviews: A critical review of studies on vitamin D in relation to colorectal cancer. Nutrition and
Cancer. 48(2):115-123, 2004. Harris D et al. Vitamin D and colon carcinogenesis. Journal of Nutrition. 134(12):3463S-3471S, 2004. Hayes C et al. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology. 49(2):277-300, 2003.
References Argiles A et al. Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purification. 20(4):370-375,
2002. Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997. Li Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical
Investigation. 110(2):229-238, 2002. Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003. Li Y et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid
Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004. Pfeifer M et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone
levels in elderly women. Journal of Clinical Endocrinology and Metabolism. 86(4):1633-1637, 2001. Sigmund C. Regulation of renin expression and blood pressure by vitamin D(3). Journal of Clinical Investigation. 110(2):155-156,
2002. Plaza S and Lamson D. Vitamin K2 in bone metabolism and osteoporosis. Alternative Medicine Reviews. 10(1):24-35, 2005. Review. Zitterman A et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the
American College of Cardiology. 41(1):105-112, 2003. Schleithoff S et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind,
randomized, placebo-controlled trial. American Journal of Clinical Nutrition. 83(4):754-759, 2006. Argiles A et al. Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purification. 20(4):370-375,
2002. Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997. Li Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical
Investigation. 110(2):229-238, 2002. Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003. Li Y et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid
Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004. Pfeifer M et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone
levels in elderly women. Journal of Clinical Endocrinology and Metabolism. 86(4):1633-1637, 2001. Sigmund C. Regulation of renin expression and blood pressure by vitamin D(3). Journal of Clinical Investigation. 110(2):155-156,
2002.